Boston Scientific Corporation (BSX)
$42.73+1.64%Close
SELLRECOVERY · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.9%–86.7%
- Market cap
- $63.5B
- Beta
- 0.57
- P/E (TTM)
- 17.01
- IV-%ile
- 58
- IV ATM
- 37.1%
- Short % float
- 2.80%
- Days to cover
- 1.9
- SI change
- -10.9%
- 1W
- +0.31%
- 1M
- -0.86%
- vs SPY 1W
- -0.86%
- vs SPY 1M
- -3.85%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic plc$111.5BBEARQ 14$87.09+0.83%
- EWSELLEdwards Lifesciences Corporation$49.8BBEARQ 18$86.48+1.15%
- PENSELLPenumbra, Inc.$12.5BBULLQ 27$317.05+0.59%
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$124.74+0.75%
- MMSISELLMerit Medical Systems, Inc.$5.1BBEARQ 13$84.96+2.30%
- LIVNSELLLivaNova PLC$4.1BBEARQ 2$74.93+0.63%
- ATRCSELLAtriCure, Inc.$2.7BBEARQ 19$53.68+5.62%
- CNMDSELLCONMED Corporation$1.3BRECOVERYQ 13$44.48-1.53%
- ANGOSELLAngioDynamics, Inc.$596MCRISISQ 4$14.42+2.58%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BSX?
- LOPJLB’s latest quantitative signal on Boston Scientific Corporation (BSX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BSX in?
- Boston Scientific Corporation (BSX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Boston Scientific Corporation (BSX) do?
- Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…